People

The AuToDeCRA-2 study is sponsored by The Newcastle upon Tyne Hospitals NHS Foundation Trust and led by Professor John Isaacs and his team of researchers at Newcastle University. The study is running within the Clinical Research Facility at the Royal Victoria Infirmary, part of The Newcastle upon Tyne Hospitals NHS Foundation. The experimental medicine, TolDC, is manufactured by Newcastle Advanced Therapies.

Professor John Isaacs

  • Newcastle BRC Deputy Director and Research Director, Newcastle Hospitals
  • Chief Investigator

Professor Catharien Hilkens

  • Professor of Immunotherapy
    • Newcastle University

Dr Arthur Pratt

  • Clinical Senior Lecturer, Honorary Consultant Rheumatologist
    • Newcastle University, Newcastle upon Tyne Hospitals NHS Foundation Trust

Dr Ema-Louise Long

Dr Philip Brown

  • Clinical Research Associate
    • Newcastle University

Dr Amy Anderson

  • Senior Research Associate
    • Newcastle University

Julie Diboll

  • Research Technician
    • Newcastle University

Ioana Nicorescu

  • Research Fellow
    • Newcastle University

Nicky Moyse

  • Production Manager, GMP manufacturing
    • Newcastle Advanced Therapies

Dr Asma Abdul Malek

  • Research Associate
    • Newcastle University

Dawn Hiles

  • Quality assurance and control manager
    • Newcastle Advanced Therapies

The following members of staff from Newcastle Clinical Trials Unit are no longer working on the study now that all participant visits have been completed:

Nicola Goudie (Senior Trial Manager)

Michael White (Trial Manager)

Julia Phillipson (Data Manager)

Julie Thompson (Data Manager)

Laura Robertson (Clinical Trial Administrator)